Abstract
Background and aim
Vascular calcification is one of the most prevalent disorders in pediatric hemodialysis patients that eventually lead to cardiovascular morbidity. Vitamin K2 was investigated in adults in previous studies and showed favorable effects on calcification markers. Our aim in this study was to evaluate the efficacy and safety of vitamin K2 and cholecalciferol on the calcification regulators in pediatric patients.
Methods
A prospective, randomized and controlled trial was conducted on sixty hemodialysis pediatric patients who were divided to four groups; Group 1: administered 100 µg of vitamin K2 (MK-7); Group 2: administered 10 µg of native vitamin D; Group 3: administered 100 µg of vitamin K2 (MK-7) in addition 10 µg of native vitamin D, and Group 4: administered the standard therapy only. The duration of supplementation was 4 months. In addition to a group of healthy normal control of age and sex-matched.
Results
At the end of the study period, serum levels of FGF23, dp-uc-MGP, and uc-OC were measured. It was found that serum levels of dp-uc-MGP, uc-OC, and FGF23 were significantly higher (p < 0.05) in the hemodialysis patients as compared to the healthy normal control. After 4 months, group 3 revealed the most significant decrease in dp-uc-MGP, uc-OC as compared to the other groups. However, there was no change in FGF23.
Conclusion
Vitamin K2 and native vitamin D showed a beneficial effect on calcification regulators in pediatric hemodialysis patients.
Trial registration
clinical trial.gov (NCT04145492).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pilar S, Chin Y, Yiwen L, Leilani E, Sadia A, Anne P, et al. Arterial “inflammaging” drives vascular calcification in children on dialysis. Kidney Int. 2019;95:958–72.
London G, Guerin A, Marchais S, Métivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. NDT. 2003;18:1731–40.
Russo D, Corrao S, Battaglia Y, Andreucci M, Caiazza A, Carlomagno A, et al. Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis. Kidney Int. 2011;80:112–18.
Paloian N, Giachelli C. A current understanding of vascular calcification in CKD. Am J Physiol Ren Physiol. 2014;307:F891–F900.
Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38:938–42.
Shroff R, Shanahan C. The vascular biology of calcification. Semin Dial. 2007;20:103–09.
Delanaye P, Krzesinski JM, Warling X, Moonen M, Smelten N, Médart L, et al. Dephosphorylated- uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. BMC Nephrol. 2014;15:145.
Schurgers J, Cranenburg C, Vermeer C. Matrix Gla protein: the calcification inhibitor in need of vitamin K. Thromb Haemost. 2008;100:593–603.
Berkner K, Runge K. The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis. J Thromb Haemost. 2004;2:2118–32.
Schurgers J, Teunissen J, Hamulyak K, Knapen M, Vik H, Vermeer C. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood. 2007;109:3279–83.
Malyszko J, Wolczynski S, Skrzydlewska E, Małyszko J, Myśliwiec M. Vitamin K status in relation to bone metabolism in patients with renal failure. Am J Nephrol. 2002;22:504–08.
Kalantar-Zadeh K, Kovesdy CP. Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:1529–39.
Kovesdy CP, Ahmad Zadeh S, Anderson JE, Kalantar- Zadeh K. Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med. 2008;168:397–403.
Gonz´alez EA, Sachdeva A, Oliver A, Martin KJ. Vitamin D insufficiency and deficiency in chronic kidney disease: a single center observational study. Am J Nephrol. 2004;24:503–10.
Kim SM, Choi HJ, Lee JP, Kim DK, Oh YK, Kim YS, et al. Prevalence of vitamin D deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney disease. J Ren Nutr. 2014;24:20–25.
Do-Houn K, Cesar AM, Holly C, Jeong-Su K, Robert CH. Vitamin D and endothelial function. Nutrients. 2020;12:575. 10.3390
Mario C, Michela M, Andrea G, Paola C, Piergiorgio M, Sagar N. Vitamin K in chronic kidney disease. Nutrients. 2019;11:168. 10.3390
Su Mi L, Won Suk A. Supplementary nutrients for prevention of vascular calcification in patients with chronic kidney disease. Korean J Intern Med. 2019;34:459–69.
Caluwé R, Vandecasteele S, Van Vlem B, Vermeer C, De Vriese A. Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study. Nephrol Dial Transpl. 2014;29:1385–90.
Bentkowski W, Kuzniewski M, Fedak D, Dumnicka P, Kuśnierz-Cabala B, Janda K, et al. Undercarboxylated osteocalcin (Glu-OC) bone metabolism and vascular calcification in hemodialyzed patients. Prz Lek. 2013;70:703–06.
Holden RM, Morton AR, Garland JS, Pavlov A, Day A, Booth S. Vitamins K and D status in stages 3–5 chronic kidney disease. CJASN. 2010;5:590–97.
Pilkey RM, Morton AR, Boffa MB, Noordhof C, Day A, Su Y, et al. Subclinical vitamin K deficiency in hemodialysis patients. Am J Kidney Dis. 2007;49:432–39.
Westenfeld R, Krueger T, Schlieper G, Cranenburg E, Magdeleyns E, Heidenreich S, et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis. 2012;59:186–95.
Kurnatowska I, Grzelak P, Masajtis-Zagajewska A, Kaczmarska M, Stefańczyk L, Vermeer C, et al. Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3–5. Pol Arch Med Wewn. 2015;125:631–40.
Aoun M, Makki M, Azar H, Matta H, Chelala D. High dephosphorylated- uncarboxylated MGP in hemodialysis patients: risk factors and response to vitamin K2, A pre-post intervention clinical trial. BMC Nephrol. 2017;18:191.
Oikonomaki T, Papasotiriou M, Ntrinias T, Kalogeropoulou C, Zabakis P, Kalavrizioti D, et al. The effect of vitamin K2 supplementation on vascular calcification in hemodialysis patients: a 1-year follow-up randomization trial. Int Urol Nephrol. 2019;51:2037–44.
Funding
No source of funding from National Institute of Health (NIH); Welcome Trust: Howard Hughes Medical Institute (HHMI) & others.
Author information
Authors and Affiliations
Contributions
R.E.B. and M.S.E.-F. designed the study, M.S.E.-F. performed the study, R.E.B. analysed the data and wrote the draft version of the paper. Finally, R.E.B. and M.S.E.-F. edited and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
El Borolossy, R., El-Farsy, M.S. The impact of vitamin K2 and native vitamin D supplementation on vascular calcification in pediatric patients on regular hemodialysis. A randomized controlled trial. Eur J Clin Nutr 76, 848–854 (2022). https://doi.org/10.1038/s41430-021-01050-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41430-021-01050-w